China Health Industries Holdings Inc CHHE 上一季度的收入表现如何?
China Health Industries Holdings Inc 的收入预期是多少?
China Health Industries Holdings Inc 的盈利质量评分是多少?
China Health Industries Holdings Inc 何时发布财报?
China Health Industries Holdings Inc 的预期收益是多少?
China Health Industries Holdings Inc 是否超出收益预期?
关键数据
前收盘价
$0.0001
开盘价
$0
当日区间
$0 - $0
52周范围
$0 - $0.2225
交易量
1.0K
平均成交量
0
每股收益(TTM)
-0.02
股息收益率
--
市值
$6.5K
什么是 CHHE?
China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm's products include soft capsule, hard capsule, tablet, granule, oral liquid forms which address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.